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Background: Survival after primary ICD implantation may differ between trial evidence and Medicare patients, for whom we determined survival 
after primary ICD in relation to the baseline heart failure (HF) burden.
Methods: Linking data from the CMS ICD registry and Medicare files (2005-2008), we identified 66,974 (73% male, 88% white, mean age 75) 
primary prevention ICD recipients ≥66 yrs with ejection fraction ≤35%. Prior HF hospitalizations (prior-HF-hosp) and length of current hospitalization 
prior to implantation (pre-implant- day) were used to define HF burden. All cause mortality curves and crude mortality/age-sex-race adjusted hazard 
ratios (adj. HRs) were estimated using proportional hazards regression.
Results: Of all ICD recipients, 11,876 died during a mean follow-up of 1.4 yrs (3-yr-mortality 31% [95% CI: 30-32]). By 3 years, mortality with ICD 
implanted after ≥3 prior HF hosps was 60% (adj. HR 3.3), versus 27% in patients without prior HF hosps, which was closer to survival in major ICD 
trials (Figure). Mortality at 3-yrs was 25% in patients with no pre-implant- day versus 52% in those with >1-week pre-implant- day (adj. HR: 3.2).
Conclusion: About 1/3 of Medicare ICD recipients are dead by 3 years. Survival in trials providing evidence of ICD benefit is most similar to 
survival for Medicare patients without prior or current HF hospitalization. Pre-existing burden of chronic and acute heart failure should be included 
in consideration of primary ICD implantation among Medicare patients.
 
